2009
DOI: 10.1177/1099800409346333
|View full text |Cite
|
Sign up to set email alerts
|

The Role of Doxycycline as a Matrix Metalloproteinase Inhibitor for the Treatment of Chronic Wounds

Abstract: Many chronic wounds fail to heal with conventional therapy, resulting in disability and impaired quality of life. New technologies using recombinant growth factors, autologous growth factors, or bioengineered skin-tissue substitutes have been shown to be effective, but these treatments are costly. An effective, low-cost treatment to improve healing of chronic wounds is needed. The molecular environment of chronic wounds, like many other chronic inflammatory diseases, contains abnormally high levels of proinfla… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
61
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(67 citation statements)
references
References 56 publications
1
61
0
1
Order By: Relevance
“…Doxycycline can also impact the gut microbiota in humans; the direct impact of this on adipose biology is unclear but potentially significant (Angelakis et al 2014). Furthermore, doxycycline can regulate the function of matrix metalloproteinases (Stechmiller et al 2010). Nevertheless, we are presently unaware of data that would suggest that short-term doxycycline exposure directly impacts adipose tissue turnover in a manner that would confound lineage tracing studies.…”
Section: Perspectives Limitations and Future Directionsmentioning
confidence: 99%
“…Doxycycline can also impact the gut microbiota in humans; the direct impact of this on adipose biology is unclear but potentially significant (Angelakis et al 2014). Furthermore, doxycycline can regulate the function of matrix metalloproteinases (Stechmiller et al 2010). Nevertheless, we are presently unaware of data that would suggest that short-term doxycycline exposure directly impacts adipose tissue turnover in a manner that would confound lineage tracing studies.…”
Section: Perspectives Limitations and Future Directionsmentioning
confidence: 99%
“…Doxycycline has been experimentally shown to reduce tissue degradation (Bildt et al, 2009;Li et al, 2013) and its activity as an MMP inhibitor makes it attractive as a potential treatment for chronic wounds (Naidoo et al, 2009;Stechmiller et al, 2010). The MMP inhibitory action of doxycycline is independent of its antimicrobial properties and thus unrelated to its inhibitory effect on bacterial protein synthesis.…”
Section: Introductionmentioning
confidence: 99%
“…Although the full mechanism has yet to be elucidated, it is believed to inhibit enzymatic MMP activity through the chelation of the zinc molecule and MMP gene expression (Li et al, 2013). Doxycycline's inhibitory activity extends to TNFa-converting enzyme (TACE), a molecule that causes release of tumor necrosis factor-alpha (TNFa), which is an important inflammatory mediator known to impair wound healing (Stechmiller et al, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Tetrasiklinler ve KMT'lerin nötrofil, sitokin ve MMP'leri inhibe edebilme özelliğine bağlı olarak yara iyileşmesini hızlandırdıkları bildirilmiştir. Ayrıca topikal doksisiklin MMP inhibisyonu ile yara iyileşmesini hızlandırdığı gösterilmiştir [24] . Kaposi sarkomunda MMP-2 ve MMP-9 düzeylerinde artış olması üzerine KMT-3 ile faz 2 çalışma sonuçlarında anlamlı olmasa da tetrasiklinlerin etkili olduğu gösterilmiş, tetrasiklin tedavisi ile MMP-2 ve MMP-9 seviyelerinin anlamlı olarak azaldığı gösterilse de, MMP inhibitörleri ile yapılan çalışmalar sonuçsuz kalmıştır [25,26] .…”
Section: Anti-enflamatuvar Etkiunclassified